Targeted glucose or glutamine metabolic therapy combined with PD-1/PD-L1 checkpoint blockade immunotherapy for the treatment of tumors: mechanisms and strategies

Disclosures: Yayun Ren: HistoIndex Pte Ltd: Employee, Dean Tai: Histoindex.com: Employee, Elaine Chng: Nothing to Disclose, Kutbuddin Akbary: HistoIndex Pte Ltd: Employee, Nikolai Naoumov: Nothing to Disclose, Jonathan Fallowfield: Stimuliver: Advisor, Ipsen: Advisor, Kynos Therapeutics: Advisor, Resolution Therapeutics: Consultant, River 2 Renal Corp.: Advisor, Global Clinical Trial Partners: Advisor, Guidepoint: Consultant, GlaxoSmithKline: Grant/Research Support, Genentech: Grant/Research Support, Intercept Pharmaceuticals: Grant/Research Support, Timothy Kendall: Nothing to Disclose, David Kleiner: Nothing to Disclose, Arun Sanyal: Genfit, Akarna, Tiziana, Durect, Inversago, Hemoshear, North: Stock - publicly traded company, Astra Zeneca ( 60K), Boston Pharmaceutical ( 2) in efforts to improve clinical outcomes and prevent cirrhosis by performing early intervention

Learn more: All you need to know about glutathione skin whitening injections Meanwhile, glutathione skin whitening injection has large amounts of vitamin C (it boosts glutathione and its secretion by the body)
The itch VAS [18], skin pain VAS [19], and fatigue VAS [20] are 0100 mm horizontal lines on which patients place a mark representing their perceived worst itch, pain, and fatigue, respectively, within the past week from 0 (none) to 100 (most severe)